GH Secretagogues · Ghrelin Mimetics Research Compounds Older Generation GHRPs

GHRP-2
& GHRP-6

Growth Hormone Releasing Peptide-2 · Pralmorelin · GHRP-6 · His-DTrp-Ala-Trp-DPhe-Lys

"The originals. Before ipamorelin, GHRP-2 and GHRP-6 defined the GH secretagogue category. More powerful than ipamorelin — and less selective. Understanding why they were replaced clarifies everything about what ipamorelin does differently."

GHRP-2
More potent · raises cortisol · minimal hunger
GHRP-6
Strong GH · significant hunger stimulation
Receptor
GHSR-1a (ghrelin receptor)
FDA Status
Not approved · Research only
WADA
Prohibited
Origin & Background

The first generation GH secretagogues

GHRP-2 and GHRP-6 are synthetic hexapeptides that were among the first ghrelin receptor (GHSR-1a) agonists developed for research into growth hormone secretion. They were synthesised in the 1980s and 1990s as part of the effort to understand how ghrelin — the stomach's hunger hormone — stimulates GH release from the pituitary independently of GHRH.

Both peptides bind the GHSR-1a receptor with high affinity and produce substantial GH release. In multiple clinical studies, GHRP-2 was found to be more potent than GHRP-6 for GH stimulation. However, both produce side effects that ipamorelin — specifically designed to be selective — largely avoids. This is the key reason ipamorelin overtook them as the preferred GHRP in clinical practice: ipamorelin produces comparable or greater GH release with a much cleaner side effect profile.

Despite being superseded by ipamorelin in most clinic protocols, GHRP-2 and GHRP-6 remain widely used in the biohacking community — partly because they are cheaper, partly because the hunger stimulation from GHRP-6 is considered a feature by some users in bulking phases, and partly because the community established protocols around them before ipamorelin became widely available.

Why GHRP-2 and GHRP-6 still matter: Understanding them clarifies the entire GHRP category. They demonstrate that ghrelin receptor agonism is the mechanism — and that selectivity matters enormously within that mechanism. GHRP-2 also holds the distinction of being studied in a 47-fold GH pulse amplification study when combined with GHRH, establishing the synergistic dual-receptor principle that underlies all modern GH secretagogue combination protocols.

Science & Mechanism

Non-selective ghrelin receptor activation

GHRP-2 vs GHRP-6 vs Ipamorelin

1
GHSR-1a binding (all three): GHRP-2, GHRP-6, and ipamorelin all bind the ghrelin receptor (GHSR-1a) on pituitary somatotrophs, activating phospholipase C and calcium signalling to trigger GH release. This is the shared mechanism.
2
GHRP-2 — potent but cortisol-raising: GHRP-2 produces strong GH release (up to 47x baseline in synergy with GHRH) but also stimulates ACTH and cortisol release. Elevated cortisol is catabolic — counterproductive in the anabolic context where GH secretagogues are typically used. Also mildly raises prolactin.
3
GHRP-6 — GH plus hunger: Produces significant GH release but also strongly activates ghrelin's primary physiological role — stimulating hunger via the hypothalamus. Users report intense food cravings 20–45 minutes post-injection. This hunger stimulation is mediated by the same GHSR-1a receptor, demonstrating that the receptor has multiple downstream effects.
4
Ipamorelin — selective GHSR agonism: Raun et al. (1998) established that ipamorelin activates GHSR-1a without stimulating cortisol, ACTH, prolactin, or significant hunger. This selectivity is the result of different binding characteristics at the receptor — ipamorelin activates the GH-releasing pathway without triggering the off-target effects of the older GHRPs.
5
GHRH synergy (all three): When any GHRP is combined with a GHRH analogue (Mod-GRF, sermorelin, CJC-1295), GH release is synergistically amplified 3–5x (ipamorelin) to 47x (GHRP-2 at high dose). This dual-receptor activation is the basis for all combination GH secretagogue protocols.
GHRP-2 Profile
GH potencyVery high
Cortisol↑ Raised
Prolactin↑ Mildly raised
HungerMild increase
Typical dose100–300mcg SubQ
Half-life~15–60 minutes
GHRP-6 Profile
GH potencyHigh
Cortisol↑ Mildly raised
Prolactin↑ Raised
HungerStrong — "the hunger GHRP"
Typical dose100–300mcg SubQ
Half-life~15–60 minutes
Community Voices

What people report

Anecdotal ReportNot medical evidence · Individual experience

"GHRP-6 on a bulk is a cheat code for appetite. I inject 200mcg before lunch and I'm ravenous within 30 minutes. Combined with Mod-GRF the GH pulse is massive. The hunger is a feature, not a bug when you're trying to eat 4,000 calories a day."

Male, 26, competitive bodybuilder. GHRP-6's hunger stimulation is explicitly used by bulking athletes as an appetite amplifier. This is its most distinct characteristic versus ipamorelin — and whether it is a feature or a side effect depends entirely on your goals.

Anecdotal ReportNot medical evidence · Individual experience

"GHRP-2 gave me the strongest GH pulses I've measured on bloodwork — but I felt anxious and on-edge in a way I don't with ipamorelin. That's the cortisol. Once I understood that's what was happening I switched protocols. Still use it occasionally for its raw potency."

Male, 34, experienced peptide user with regular bloodwork monitoring. The subjective cortisol effect from GHRP-2 — low-grade anxiety, restlessness — is consistently reported and is the most common reason users switch to ipamorelin for regular use.

Benefits & Evidence

What the data shows

📈
GH release — among the most potent available
GHRP-2 in combination with GHRH produced 47-fold increase in pulsatile GH secretion in hypogonadal men (Sinha et al.). Both compounds produce robust GH stimulation with a well-established mechanism. The raw GH potency exceeds ipamorelin at equivalent doses.
● Moderate — clinical studies exist, no Phase III
💪
Body composition (via GH/IGF-1)
The downstream body composition effects of elevated GH — lean mass increase, lipolysis, improved recovery — apply to all GHRPs. GHRP-6's hunger stimulation may support caloric surplus for muscle building in bulking phases.
● Moderate — extrapolated from GH literature
🔬
Research utility — diagnostic GH testing
GHRP-2 is used clinically as a GH stimulation test agent in some countries for diagnosing GH deficiency — a legitimate diagnostic application with a clear evidence base. Not a consumer application but demonstrates the clinical seriousness of the compound.
● Strong — diagnostic use with clinical evidence
Safety First

Risks & considerations

⚠️
The main safety concern unique to GHRP-2 and GHRP-6 is their non-selectivity. The cortisol elevation from GHRP-2 is catabolic — counterproductive for muscle building and potentially problematic with chronic use. The prolactin elevation from GHRP-6 can suppress testosterone and libido. Neither effect occurs with ipamorelin. These are not theoretical risks — they are documented in the clinical literature and reported consistently by users.
Moderate
Cortisol elevation (GHRP-2) — ACTH stimulation raises cortisol. Chronically elevated cortisol is catabolic, suppresses immune function, and contributes to anxiety and poor sleep. The very effect that makes GHRP-2 less desirable than ipamorelin for regular use.
Moderate
Prolactin elevation (GHRP-6) — raises prolactin which can suppress testosterone and libido in men and cause menstrual irregularities in women with chronic use at higher doses.
Mild
Intense hunger (GHRP-6) — the ghrelin receptor hunger signal is strong and predictable within 30 minutes of injection. A feature in bulking contexts, a significant problem when trying to maintain caloric control.
Moderate
Water retention and IGF-1 elevation — same as ipamorelin and other GHRPs. Monitor IGF-1.
Serious
Contraindicated in active malignancy — same as all GH-axis compounds.

⚠ Key Warnings

For body composition goals, ipamorelin is strictly preferable to both GHRP-2 and GHRP-6. It produces comparable GH release without cortisol or prolactin elevation. The only reason to use GHRP-2 or GHRP-6 over ipamorelin is cost or specific use cases (GHRP-6 hunger for bulking).
Monitor cortisol if using GHRP-2 regularly — particularly relevant for people who are already under chronic stress or running high-intensity training programmes.
WADA prohibited at all times for competitive athletes.
Inject fasted — same insulin-GH interaction applies as with all GHRPs.
Synergy Stack

Nutrients, Supplements & Exercise

The synergies for GHRP-2 and GHRP-6 mirror ipamorelin — but with additional considerations for managing cortisol (GHRP-2) and hunger (GHRP-6).

💊 Nutrients & Supplements
Mod-GRF 1-29 (primary combination)
100mcg alongside every GHRP injection
Strong evidence
Same dual-receptor synergy as with ipamorelin. GHRH + GHRP activates two independent pituitary pathways producing 3–47x more GH than either alone. This combination principle is the same regardless of which GHRP is used.
Ashwagandha (for GHRP-2 users)
300–600mg/day KSM-66
Moderate evidence
GHRP-2 raises cortisol — ashwagandha reduces it via HPA axis modulation. This is the most rational co-intervention for regular GHRP-2 users who want to blunt the catabolic cortisol elevation while retaining the GH benefits.
Protein (prioritise if using GHRP-6)
Eat protein first at GHRP-6 hunger windows
Strong evidence
GHRP-6 hunger hits 20–45 minutes post-injection. If using GHRP-6 during caloric restriction, ensure the hunger window is met with protein-dominant meals rather than high-carbohydrate foods to avoid undoing the GH-driven lipolysis.
No carbs at injection time
Fasted injections only
Strong evidence
Insulin suppresses GH release — same principle as all GH secretagogues. Inject GHRP fasted (morning before breakfast, or 2+ hours post-meal before bed). The GHRP-6 hunger that follows is best managed by having a protein-focused meal ready 30 minutes after injection.
🏃 Exercise & Lifestyle
Resistance training
Same principle as all GH secretagogues — mechanical load directs the anabolic GH/IGF-1 signal toward muscle tissue. Required for meaningful body composition benefit.
Stress management (GHRP-2 users)
GHRP-2 already raises cortisol. Adding chronic life stress compounds this. Meditation, breathwork, or adequate rest are more important when using GHRP-2 than with ipamorelin.
Plan meals around GHRP-6 hunger (if cutting)
Schedule GHRP-6 injections to coincide with planned meal times. If cutting, having a high-protein meal prepared for 30–45 minutes post-injection prevents the hunger from leading to unplanned eating.
⏱ Timing & Protocol Notes
Standard: 100–300mcg GHRP-2 or GHRP-6 SubQ, combined with 100mcg Mod-GRF, 2–3x daily (morning fasted, post-workout fasted, before bed). For GHRP-6: plan meals 30–45 minutes post-injection. For GHRP-2: consider ashwagandha daily and morning cortisol monitoring. Cycle 12–16 weeks, 4–8 weeks off.

Bottom line: If you are choosing between GHRP-2, GHRP-6, and ipamorelin for a body composition protocol, ipamorelin is the superior choice in almost all circumstances. Consider GHRP-2 or GHRP-6 only if cost is prohibitive or if the specific hunger effect of GHRP-6 is intentionally desired.

Honest Assessment

Editor's summary

GHRP-2 and GHRP-6 are historically important — they established the ghrelin receptor as a viable GH stimulation target and defined the GHRP category. The 47-fold GH synergy study with GHRP-2 and GHRH is foundational research that still informs combination protocols today.

In current practice, both have been largely superseded by ipamorelin for most applications. The cortisol elevation of GHRP-2 and the prolactin elevation and hunger stimulation of GHRP-6 are pharmacological downsides that ipamorelin was specifically engineered to avoid. The GH output is comparable or greater — but at a cost that generally isn't worth paying when ipamorelin is available.

The exceptions: GHRP-6 for deliberate appetite augmentation in caloric surplus phases, GHRP-2 for maximum GH output when the cortisol side effect is acceptable, or budget-constrained situations where GHRP-2/6 cost significantly less than ipamorelin.

Verdict
"The first generation — powerful, imperfect, and ultimately superseded by ipamorelin for most purposes. Still useful in specific contexts (GHRP-6 for appetite, GHRP-2 for maximum GH potency). Understanding them explains why ipamorelin exists and why selectivity matters in peptide pharmacology."